N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting With Cell Membrane and Targeting Mitochondria in Breast Cancer Cells
Development of antimicrobial peptides (AMPs) as highly effective and selective anticancer agents would represent great progress in cancer treatment. Here we show that myristoyl-CM4, a new synthetic analog generated by N-myristoylation of AMPs CM4, had anticancer activity against MCF-7, MDA-MB-231, M...
Main Authors: | Caiyun Li, Hongyan Liu, Yunqing Yang, Xixi Xu, Tongtong Lv, Huidan Zhang, Kehang Liu, Shuangquan Zhang, Yuqing Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01297/full |
Similar Items
-
Novel peptide myristoly-CM4 induces selective cytotoxicity in leukemia K562/MDR and Jurkat cells by necrosis and/or apoptosis pathway
by: Zhang H, et al.
Published: (2019-07-01) -
Profiling of myristoylation in Toxoplasma gondii reveals an N-myristoylated protein important for host cell penetration
by: Malgorzata Broncel, et al.
Published: (2020-07-01) -
Myristoylation profiling in human cells and zebrafish
by: Malgorzata Broncel, et al.
Published: (2015-09-01) -
Protein Lipidation by Palmitoylation and Myristoylation in Cancer
by: Chee Wai Fhu, et al.
Published: (2021-05-01) -
Design and Characterization of Myristoylated and Non-Myristoylated Peptides Effective against <i>Candida</i> spp. Clinical Isolates
by: Francesca Bugli, et al.
Published: (2022-02-01)